Both IL4RPep-1-FITC (~0.59%) and NSSSVDK-FITC (~0.53%) showed no binding in 4T1 cells (In vitro IL4R-expression-lacking mouse breast cancer cells [52]) (Figure 4C). Here, IL4R is linked to breast carcinoma.